alexa Intestinal Microbiota: An Emerging Target for Modifying
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Intestinal Microbiota: An Emerging Target for Modifying Cardiovascular Health

Shalin S Patel1, Mazyar Malakouti2, Salil Sethi1 and Robert J Chilton1*

1Division of Cardiology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

2Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

*Corresponding Author:
Dr. Robert J. Chilton
Division of Cardiology
Department of Medicine
University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Tel: 210-279-1248
E-mail: [email protected]

Received date: September 16, 2014; Accepted date: October 29, 2014; Published date: October 31, 2014

Citation: Patel SS, Malakouti M, Sethi S, Chilton RJ (2014) Intestinal Microbiota: An Emerging Target for Modifying Cardiovascular Health. J Diabetes Metab 5:459. doi: 10.4172/2155-6156.1000459

Copyright: © 2014 Patel SS, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

The rising prevalence of obesity and Type 2 diabetes mellitus (T2DM) worldwide is a primary public health concern as it heavily impacts risk of cardiovascular disease (CVD) and other comorbid diseases. Promising research in the last decade implicates gut microbiota as an important contributor to risk of developing obesity, T2DM and CVD. Animal models of obesity and insulin resistance identify that germ free mice have decreased risk of obesity and insulin resistance despite being on high fat sugar rich diet compared to conventional mice. Obesity is shown to be transmissible through faecal microbiome transplantation from obese phenotype mice to germ free mice. There is also growing evidence that gut microbiota metabolism of choline to Trimethylamine-N-Oxide (TMAO) is directly linked to increased cardiovascular risk. TMAO is a proatherogenic molecule which has been shown to increase atherosclerotic plaque burden in murine atherosclerosis model. Also, clinical cohort studies have established increased TMAO levels as an independent predictor for major adverse cardiovascular events including death, myocardial infarction and stroke. As it stands, intestinal microbiota-mediated pathogenesis of obesity, T2DM and CVD is still an emerging research direction and has the potential for leading to new diagnostic and therapeutic strategies.

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords